XTAE
RAVD
Market cap77mUSD
Oct 09, Last price
888.30ILS
1D
-0.58%
1Q
32.16%
Jan 2017
38.33%
Name
Ravad Ltd
Chart & performance
P/E
—
P/S
27.68
EPS
—
Div yield, %
8.41%
Shrs. gr., 5y
—
Rev. gr., 5y
-9.85%
Revenues
8m
+6.40%
Net income
-18m
L
CFO
-24m
L+310.32%
Dividend
Apr 06, 202576.421 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ravad Ltd. engages in the development and sale of freehold lands. It operates through the following segments: Profitable Real Estate, Nursing Home Management in England, and Residential Real Estate Development in Israel. The Profitable Real Estate segment purchased, holds, and sells real estate assets in Israel and outside the country. The Nursing Home Management in England segment manages, maintains, and operates nursing homes in England. The Residential Real Estate Development in Israel segment constructs building for residences, offices, and commerce in Tel Aviv. The company was founded on September 27, 1951 and is headquartered in Tel Aviv, Israel.
Key people
Chairman of the Board · since 2019
Co-Chief Executive Officer · since 2019
Adi Shehor
Chief Financial Officer · since 2011
Michael Bar Asher
Senior Finance Director · since 2018
Lior Fisher
Controller · since 2011
Boris Bangayev
Finance Director Assistant · since 2018
Director · since 2019
Ephraim Kunda
Director · since 2007
Izhak Oz
Director · since 2019
Yigal Zemah
Director · since 2019
Keren Bar-Hava
External Director · since 2019
Pnina Dvorin
External Director · since 2007
External Director · since 2016
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||